Step up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among Nigerians
Step up to Health, Nigeria! Utilizing Information From Abuja's 2022 World Cancer Day Walk for Equity-based Cancer Prevention Interventions
1 other identifier
interventional
527
1 country
1
Brief Summary
Cancer awareness is a critical element of cancer prevention and control. Creating public awareness on risk factors, preventative strategies, and the importance of early screening is the foundation upon which a cancer control program must be constructed. The purpose of this study is to describe the sociodemographic and risk factor distribution of the Abuja, Nigeria "World Cancer Day Walk" participants according to their motive for participating in the event (free cancer screening versus fun/activities), and secondarily, to investigate the impact of the event on educating attendees from the general population about cancer prevention and screening, in particular the importance of being physically active and maintaining a healthy body weight. Obesity is a known risk factor contributing to the development of cancer and NCD's.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2022
CompletedStudy Start
First participant enrolled
February 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2022
CompletedFirst Posted
Study publicly available on registry
February 14, 2022
CompletedFebruary 14, 2022
February 1, 2022
Same day
February 3, 2022
February 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare the sociodemographic and risk factor distribution of the "World Cancer Day Walk" participants who are attending the event for "free breast, cervical or prostate screening" with participants who are attending for "fun and activities".
The brief survey instrument captures participant sociodemographic characteristics. Participants are asked to provide known risk factors for cancer and to indicate if they are attending for "free cancer screening" or "fun/activities".
Pre-intervention
Secondary Outcomes (1)
Compare physical activity metrics between those who are attending "World Cancer Day Walk" for the first time versus participants who have attended a previous "World Cancer Day Walk".
Pre-intervention
Study Arms (2)
Intervention Group
ACTIVE COMPARATORParticipants having previously attended at least once in previous years the "World Cancer Day Walk" will be considered as the group exposed to the health education intervention (returning).
Control Group
NO INTERVENTIONThe control/non-exposed group will be the participants who are attending the "World Cancer Day Walk" for the first time in 2022 (first timers) and have not yet received health education information.
Interventions
Health literacy education (cancer prevention and healthy lifestyle) and free breast, prostate, cervical cancer screening
Eligibility Criteria
You may qualify if:
- Male and Female age 18 and over
- Willing and able to converse and/or read and write in either English or Pidgin English.
You may not qualify if:
- Participants who are unable to provide informed consent to the study due to cognitive or physical impairment, based on self-report.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AshtaYoga, LLClead
- Project PINKBLUE, Health and Psychological Trust Centrecollaborator
- University Of Nigeria Teaching Hospitalcollaborator
- Vaughan A. Lewis Institute for Research and Innovationcollaborator
- Columbia Universitycollaborator
Study Sites (1)
Project Pink Blue
Abuja, Nigeria
Related Publications (5)
Rimer BK, Glassman B. Is there a use for tailored print communications in cancer risk communication? J Natl Cancer Inst Monogr. 1999;(25):140-8. doi: 10.1093/oxfordjournals.jncimonographs.a024190.
PMID: 10854470BACKGROUNDOyetunde MO. Perception and management of cancer among the Yoruba in Ibadan, Nigeria. Afr J Med Med Sci. 2010 Sep;39(3):181-92.
PMID: 21416787BACKGROUNDJemal A, Brawley OW. Increasing cancer awareness and prevention in Africa. Ecancermedicalscience. 2019 Jul 25;13:939. doi: 10.3332/ecancer.2019.939. eCollection 2019.
PMID: 31552112RESULTJedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, Afolayan E, Banjo AA, Ekanem IO, Erinomo O, Ezeome E, Igbinoba F, Obiorah C, Ogunbiyi O, Omonisi A, Osime C, Ukah C, Osinubi P, Hassan R, Blattner W, Dakum P, Adebamowo CA. Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries. Front Public Health. 2015 Jul 30;3:186. doi: 10.3389/fpubh.2015.00186. eCollection 2015.
PMID: 26284233RESULTBrawley OW. The role of government and regulation in cancer prevention. Lancet Oncol. 2017 Aug;18(8):e483-e493. doi: 10.1016/S1470-2045(17)30374-1. Epub 2017 Jul 26.
PMID: 28759387RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leigh Leibel, MSc
Columbia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2022
First Posted
February 14, 2022
Study Start
February 5, 2022
Primary Completion
February 5, 2022
Study Completion
February 5, 2022
Last Updated
February 14, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share